School-based Programme of Malaria Diagnosis and Treatment in Southern Malawi
Malaria
About this trial
This is an interventional treatment trial for Malaria focused on measuring Malawi, Case management, Rapid diagnostic tests, Artemether lumefantrine, School children, School health services, Attendance, Anaemia, Parasitic diseases
Eligibility Criteria
Inclusion Criteria:
- Student enrolled at participating schools in standards 2, 4 and 6
- Provision of informed consent from parent or guardian
- Provision of assent by student
Exclusion Criteria:
- Student unwilling to participate in the study
- Student known to have a chronic medical condition, which will affect their school attendance
Sites / Locations
- Malaria Alert Centre, College of Medicine
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Diagnosis and treatment of malaria
No intervention
School-based diagnosis and treatment of uncomplicated malaria using malaria RDTs and Artemether lumefantrine as part of Learner Treatment Kits (LTK) used by teachers. Drug: Artemether lumefantrine (artemisinin-based combination therapy [ACT], Coartem). Three-day doses of 20mg/120mg, 40mg/240mg, 60mg/360mg and 80mg/480mg Coartem are provided, according to weight, upon a positive rapid diagnostic test (RDT) result.
No intervention provided